Column GROUP Iii, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 732 shares at $17.99 ($13K) on 2020-07-30, disclosed to the SEC on 2020-08-03.
Open-market purchase of $13k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| NGM | BUY | 2023-01-23 | $191K | — | Filing → |
| TNYA | BUY | 2022-11-23 | $50.0M | — | Filing → |